Diverge Translational Science Lab focuses on tissue-based testing to enhance the understanding and development of treatments for genetic diseases. Their expertise lies in histopathology and protein expression, which are critical for assessing the biological characteristics of tissues affected by genetic disorders. This approach not only accelerates the pace of treatment development but also supports the advancement of various therapeutic strategies, including gene therapies and protein replacement therapies. The lab's extensive experience and strong connections within the industry position it favorably against competitors in the field.

Initially concentrating on skeletal muscle diseases, Diverge has broadened its scope to encompass a wide range of tissue types, thereby expanding its impact on the treatment of genetic disorders in children. By leveraging their academic background and industry partnerships, the lab aims to facilitate the development of innovative therapies that address the complexities of genetic diseases, ultimately improving patient outcomes and treatment efficacy.

United States

Our company specializes in the development and performance of tissue-based testing, focused on histopathology and protein expression, to improve the understanding and pace of treatment development for genetic diseases.

Diverge Translational Science Lab

Company Details